Found 7 matching trials
Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout N/A The primary purpose of this study is to observe patients being treated with...
Show More Location
Rheumatology Associates, PC
Learn More & Join Trial
Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis PHASE1 This is a Phase 1 single dose study conducted to evaluate the PK and PD of ...
Show More Location
Davita Clinical Research
Learn More & Join Trial
Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout PHASE4 The purpose of this study is to assess the potential for pegloticase with m...
Show More Location
University of Alabama
Learn More & Join Trial
Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout PHASE4 The overall objective of the study is to assess the efficacy, safety, toler...
Show More Location
Orthopedic Physicians Alaska
Learn More & Join Trial
A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) PHASE4 This trial is to assess efficacy, safety, blood levels and bodily effects o...
Show More Location
Orthopedic Physicians Alaska
Learn More & Join Trial
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout PHASE4 The study consists of 24-week double-blind trial to evaluate the non-inferi...
Show More Location
The University of Alabama at Birmingham (UAB)
Learn More & Join Trial
A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy PHASE2 This is a randomized, parallel-arm, multicenter study to compare the safety...
Show More Location
Pinnacle Research Group, LLC
Learn More & Join Trial